Nykode Therapeutics Share Price
Stocks
NYKD
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.765 NOK | -0.18% |
|
-0.18% | +14.64% |
| 05-27 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-27 | Nykode Therapeutics AS, Q1 2026 Earnings Call, May 27, 2026 |
| Market Cap | 903M 93.28M 81.76M 75.57M 69.5M 131M 8.99B 133M 904M 354M 4.4B 350M 343M 15.16B | P/E 2026 * |
-4.28x | P/E 2027 * | -29.9x |
|---|---|---|---|---|---|
| Enterprise Value | 418M 43.16M 37.83M 34.97M 32.16M 60.68M 4.16B 61.66M 418M 164M 2.04B 162M 159M 7.02B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 2.01x |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nykode Therapeutics
| 1 day | -0.18% | ||
| 1 week | -0.18% | ||
| Current month | -14.13% | ||
| 1 month | -14.13% | ||
| 3 months | -20.77% | ||
| 6 months | +12.12% | ||
| Current year | +14.64% |
| 1 week | 2.72 |  | 2.86 |
| 1 month | 2.72 | | 3.29 |
| Current year | 2.21 | | 4.1 |
| 1 year | 1.44 | | 4.1 |
| 3 years | 1.44 | | 30.18 |
| 5 years | 1.44 | | 85.3 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 31/12/2018 |
| President | 49 | 31/12/2016 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 02/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 22/04/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/03/25 | Buy | Company | 3,000,000 | 0.9187% | ||
| 20/12/24 | Sell | Director | 100,000 | 0.0306% | ||
| 20/12/24 | Buy | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.18% | -0.18% | +48.90% | -90.25% | 93.85M | |
| +0.21% | -0.79% | +53.17% | +57.39% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| -1.20% | -1.94% | +4.35% | +402.68% | 23.48B | |
| +0.74% | +2.32% | -16.23% | -14.44% | 23.13B | |
| +3.46% | +2.52% | +34.01% | -5.41% | 19.36B | |
| -1.18% | -2.97% | +30.12% | -33.30% | 17.56B | |
| -1.67% | -6.00% | +163.95% | +284.69% | 15.2B | |
| +3.62% | 0.00% | +29.70% | +643.91% | 14.83B | |
| -0.70% | -0.91% | +24.87% | +179.47% | 14.06B | |
| Average | +0.85% | -1.75% | +42.32% | +150.78% | 23.36B | |
| Weighted average by Cap. | +1.48% | -1.50% | +41.47% | +137.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 162M 16.71M 14.64M 13.53M 12.45M 23.49M 1.61B 23.86M 162M 63.44M 788M 62.73M 61.36M 2.72B |
| Net income | -208M -21.48M -18.83M -17.4M -16M -30.2M -2.07B -30.68M -208M -81.56M -1.01B -80.65M -78.89M -3.49B | -41.58M -4.3M -3.77M -3.48M -3.2M -6.04M -414M -6.14M -41.61M -16.31M -203M -16.13M -15.78M -698M |
| Net Debt | -485M -50.12M -43.93M -40.6M -37.34M -70.46M -4.83B -71.59M -485M -190M -2.36B -188M -184M -8.15B | -578M -59.66M -52.29M -48.34M -44.46M -83.88M -5.75B -85.23M -578M -227M -2.81B -224M -219M -9.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | NOK 2.765 | -0.18% | 219,535 |
| 17/07/26 | NOK 2.770 | -1.95% | 227,297 |
| 16/07/26 | NOK 2.825 | +1.44% | 299,423 |
| 15/07/26 | NOK 2.785 | -0.89% | 389,304 |
| 14/07/26 | NOK 2.810 | +1.44% | 313,393 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NYKD Stock
Select your edition
All financial news and data tailored to specific country editions
